Pieter Van Herck Lieven Annemans Walter Sermeus Dirk Ramaekers
10.1371/journal.pone.0078662
PLoS One
2013 Oct 30;8(10):e78662.
CC BY
https://pubmed.ncbi.nlm.nih.gov/24205290/
Decision Making Evidence-Based Practice / economics Health Policy / economics Insurance, Health, Reimbursement / economics
Decision Making Evidence-Based Practice / economics Health Policy / economics Insurance, Health, Reimbursement / economics Antibodies, Monoclonal, Humanized / economics Antibodies, Monoclonal, Humanized / therapeutic use Aorta / surgery Breast Neoplasms / diagnosis Endovascular Procedures / economics Habits Humans Lobbying Mass Media Neutrons / therapeutic use Oseltamivir / economics Oseltamivir / therapeutic use Proton Therapy / economics Trastuzumab Antibodies, Monoclonal, Humanized Oseltamivir Trastuzumab
PMC3813690
24205290
Evidence-based health care policy in reimbursement decisions: lessons from a series of six equivocal case-studies
2013